Abstract:Structure-based drug discovery (SBDD) is becoming an essential tool in assisting fast and cost-efficient lead discovery and optimization. The application of rational, structure-based drug design is proven to be more efficient than the traditional way of drug discovery since it aims to understand the molecular basis of a disease and utilizes the knowledge of the three-dimensional structure of the biological target in the process. In this review, we focus on the principles and applications of Virtual Screening (VS) within the context of SBDD and examine different procedures ranging from the initial stages of the process that include receptor and library pre-processing, to docking, scoring and post-processing of topscoring hits. Recent improvements in structure-based virtual screening (SBVS) efficiency through ensemble docking, induced fit and consensus docking are also discussed. The review highlights advances in the field within the framework of several success studies that have led to nM inhibition directly from VS and provides recent trends in library design as well as discusses limitations of the method. Applications of SBVS in the design of substrates for engineered proteins that enable the discovery of new metabolic and signal transduction pathways and the design of inhibitors of multifunctional proteins are also reviewed. Finally, we contribute two promising VS protocols recently developed by us that aim to increase inhibitor selectivity. In the first protocol, we describe the discovery of micromolar inhibitors through SBVS designed to inhibit the mutant H1047R PI3Kα kinase. Second, we discuss a strategy for the identification of selective binders for the RXRα nuclear receptor. In this protocol, a set of target structures is constructed for ensemble docking based on binding site shape characterization and clustering, aiming to enhance the hit rate of selective inhibitors for the desired protein target through the SBVS process.

Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery

Recent Developments in Structure-Based Virtual Screening Approaches

Combined strategies in structure-based virtual screening

Ultra‐Large Virtual Screening: Definition, Recent Advances, and Challenges in Drug Design

Hit me with your best shot: Integrated hit discovery for the next generation of drug targets

An artificial intelligence accelerated virtual screening platform for drug discovery

Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches

An Integrated Virtual Screening Approach for VEGFR-2 Inhibitors.

Structure-Based Virtual Screening of Chemical Libraries for Drug Discovery

Target-driven Machine Learning-Enabled Virtual Screening (TAME-VS) Platform for Early-Stage Hit Identification

Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances

Virtual Screening Methods As Tools for Drug Lead Discovery from Large Chemical Libraries.

Virtual Screening Methods As Tools For Drug Lead Discovery From Large Chemical Libraries

Structure-Based Virtual Screening: Successes and Pitfalls

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

Computer Aided Multi-target Drug Design, Multi-target Virtual Screening

Multiple-step Virtual Screening Using VSM-G: Overview and Validation of Fast Geometrical Matching Enrichment

Combined Usage of Ligand- and Structure-based Virtual Screening in the Artificial Intelligence Era

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery

Recent Development and Application of Virtual Screening in Drug Discovery: An Overview

Virtual Combinatorial Chemistry and Pharmacological Screening: A Short Guide to Drug Design